Multiple sclerosis, immunomodulators, and pregnancy outcome: A prospective observational study

Multiple Sclerosis

Volumn 15, Issue 9, 2009, Pages 1037-1042

  Weber Schoendorfer, Chrstof ^a   Schaefer, C ^a  

^a Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy   (Germany)

Author keywords

Abnormalities; Cohort study; Drug induced; Glatiramer acetate; Interferon beta; Multiple sclerosis; Pregnancy; Pregnancy outcome

Indexed keywords

BETA1A INTERFERON; FOLIC ACID; GLATIRAMER; GLUCOCORTICOID; INTERFERON BETA SERINE; IODINE; LEVOFLOXACIN; MOXIFLOXACIN; THYROXINE;

ABORTION; ADULT; ARTICLE; ATRIOVENTRICULAR CANAL; BIRTH DEFECT; BIRTH WEIGHT; CLUBFOOT; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FETOTOXICITY; HEART DISEASE; HIP DYSPLASIA; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; OBSERVATIONAL STUDY; PREGNANCY OUTCOME; PREMATURE LABOR; PRENATAL DRUG EXPOSURE; PROSPECTIVE STUDY; SPONTANEOUS ABORTION;

ABORTION, SPONTANEOUS; ADOLESCENT; ADULT; BIRTH WEIGHT; COHORT STUDIES; CONGENITAL ABNORMALITIES; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; INFANT, NEWBORN; INTERFERON-BETA; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PEPTIDES; PREGNANCY; PREGNANCY OUTCOME; RISK FACTORS; YOUNG ADULT;

EID: 69149096504     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458509106543     Document Type: Article

References (16)

1. Orton, SM, Herrera, BM, Yee, IM, et al. Sex ratio of multiple sclerosis in Canada: A longitudinal study. Lancet Neurol 2006; 5: 932-936.
2. Kappos, L, Polman, CH, Freedman, MS, et al. Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes. Neurology 2006; 67: 1242-1249.
3. Kinkel, RP, Kollman, C, OConnor, P, et al. IM interferon beta-1a delays definite multiple sclerosis 5 years after a first demyelinating event. Neurology 2006; 66: 678-684.
4. Coyle, PK, Christie, S, Fodor, P, et al. Multiple sclerosis gender issues: Clinical practices of women neurologists. Mult Scler 2004; 10: 582-588.
5. Vukusic, S, Hutchinson, M, Hours, M, et al. Pregnancy and multiple sclerosis (the PRIMS study): Clinical predictors of post-partum relapse. Brain 2004; 127: 1353-1360.
6. Confavreux, C, Hutchinson, M, Hours, MM, Cortinovis-Tourniaire, P, Moreau, T. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N Engl J Med 1998; 339: 285-291.
7. De Las Heras, V, De Andrés, C, Téllez, N, Tintoré, M.; EMPATIE Study Group. Pregnancy in multiple sclerosis patients treated with immunomodulators prior to or during part of the pregnancy: a descriptive study in the Spanish population. Mult Scler 2007; 13: 981-984.
8. Sandberg-Wollheim, M, Frank, D, Goodwin, TM, et al. Pregancy outcomes during treatment with interferon beta-1a in patients with multiple sclerosis. Neurology 2005; 65: 802-806.
9. Boskovic, R, Wide, R, Wolpin, J, Bauer, DJ, Koren, G. The reproductive effects of beta interferon therapy in pregnancy: A longitudinal cohort. Neurology 2005; 65: 807-811.
10. Patti, F, Cavallaro, T, Lo Fermo, S, et al. Is in utero earlyexposure to interferon beta a risk factor for pregnancy outcomes in multiple sclerosis. J Neurol 2008; 255: 1250-1253.
11. Coyle, PK, Johnson, K, Pardo, L, Stark, K. Pregnancy outcomes in patients with multiple sclerosis treated with glatiramer acetate (Copaxone). J Neurol Neurosurg Psychiatry 2003; 74: 443 [poster].
12. Merks, JHM, van Karnebeek, CDM, Caron, HN, Hennekam, RCM. Phenotypic abnormalities: Terminology and classification. Am J Med Genet 2003; 123A: 211-230.
13. Rasmussen, SA, Olney, RS, Holmes, LB, Lin, AE, Keppler-Noreuil, KM, Moore, CA. Guidelines for case classification for the national birth defects prevention study. Birth Defects Res A 2003; 67: 193-201.
14. Meister, R, Schaefer, C. Statistical methods for estimating the probability of spontaneous abortion in observational studies - analyzing pregnancies exposed to coumarin derivates. Reprod Toxicol 2008; 26: 31-35.
15. Dahl, J, Myhr, KM, Daltveit, AK, Hoff, JM, Gilhus, NE. Pregnancy, delivery, and birth outcome in women with multiple sclerosis. Neurology 2005; 65: 1961-1963.
16. Schaefer, C, Arnoy, A, Clementi, M, Meister, R, Weber-Schoendorfer, C. Using observational cohort data for studying drug effects on pregnancy outcome - Methodological considerations. Reprod Toxicol 2008; 26: 36-41.